Contents

Search

transcatheter valve-in-valve procedure

Indications: - Sapien 3 artificial heart valve FDA-approved for transcatheter valve-in-valve procedure for patients whose bioprosthetic aortic or mitral valves have failed [1]

Related

transcatheter aortic valve implantation; transcatheter aortic valve replacement (TAVI, TAVR, CoreValve system)

General

cardiac valve replacement

References

  1. FDA News Release. June 5, 2017 FDA expands use of Sapien 3 artificial heart valve for high- risk patients. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm561924.htm
  2. Davidson LJ, Davidson CJ Transcatheter Treatment of Valvular Heart Disease. A Review. JAMA. 2021;325(24):2480-2494 PMID: 34156404 https://jamanetwork.com/journals/jama/fullarticle/2781245